Ornsuda Lertbannaphong

Ornsuda Lertbannaphong

Auto-generated profile, based on publicly available information

Ornsuda Lertbannaphong

Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
LPLukana Preechasuk
Lukana Preechasuk
STSuchavadee Tantasuwan
Suchavadee Tantasuwan
SLSupawadee Likitmaskul
Supawadee Likitmaskul
JSJeerunda Santiprabhob
Jeerunda Santiprabhob
OLOrnsuda Lertbannaphong
Ornsuda Lertbannaphong
RLRaweewan Lertwattanarak
Raweewan Lertwattanarak
Purpose: This study aimed to investigate the clinical characteristics, glycemic control, and microvascular complications compared between young-onset type 1 (T1DM) and type 2 diabetes (T2DM) patients at Siriraj Hospital. Patients and Methods: We collected demographic, clinical, glycemic control, and microvascular complication data of young-onset (onset < 30 years of age) T1DM and T2DM patients at our center using February 2019-December 2020 data from the Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN). Results: Of 396 patients, 76% had T1DM and 24% had T2DM. At diagnosis, T1DM were significantly younger (9.7± 5.4 vs 16.9± 6.4 years, p< 0.001), had a lower body mass index (17.2± 4.1 vs 30.8± 7.9 kg/m2, p< 0.001), higher prevalence of diabetic ketoacidosis (DKA) (66.1% vs 13.7%, p< 0.001), and higher HbA1c level (12.8± 2.6% vs 10.9± 3.1%, p=0.002) compared to T2DM. Regarding glycemic control, the mean HbA1c at registry enrollment did not differ between groups (T1DM 8.3± 1.8% vs T2DM 8.1± 2.2%, p=0.303), but T1DM achieved HbA1c < 7% significantly less than T2DM (19.3% vs 47.8%, p< 0.001). T1DM showed deterioration of glycemic control during 10– 20 years of age, and gradually improved during 20– 30 years of age, whereas patients with T2DM showed progressive worsening of glycemic control over time. Concerning microvascular complications, the prevalence of diabetic retinopathy (10.6% vs 9%, p=0.92) and diabetic neuropathy (3.4% vs 5.5%, p=0.514) between T1DM and T2DM was not significantly different. However, T2DM had a significantly higher prevalence of diabetic nephropathy (T1DM 10.1% vs T2DM 40.2%, p< 0.001) that developed within a significantly shorter duration of diabetes (T1DM 11.0± 6.8 vs T2DM 4.3± 5.1 years, p< 0.001) compared to T1DM. Conclusion: T1DM had a significantly high prevalence of DKA at presentation, and most T1DM did not achieve the glycemic target, especially during adolescence. T2DM had a significantly higher prevalence of diabetic nephropathy that developed within a shorter duration of diabetes compared to T1DM.

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PSPranchalee Srikanchanawat
Pranchalee Srikanchanawat
JSJeerunda Santiprabhob
Jeerunda Santiprabhob
SLSupawadee Likitmaskul
Supawadee Likitmaskul
KKKhwanhatai Khemaprasit
Khwanhatai Khemaprasit
PCParichat Charoentawornpanich
Parichat Charoentawornpanich
WTWatip Tangjittipokin
Watip Tangjittipokin